Legal Representation
Attorney
David S. Jacobson
USPTO Deadlines
Next Deadline
72 days remaining
NOA E-Mailed - SOU Required
Due Date
March 03, 2026
Extension Available
Until September 03, 2026
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 12, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 12, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 29, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 29, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 19, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 19, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 19, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 19, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating autoimmune pulmonary diseases and disorders
Classification
International Classes
005